About The Study:

 

The flu is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe symptoms, and at times can lead to death. Complications of flu can include bacterial pneumonia, ear infections, sinus infections, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes.

Anyone can get flu, and serious problems related to flu can happen at any age, but some people are at high risk of developing serious flu-related complications if they get sick. This includes people 65 years and older, people of any age with certain chronic medical, pregnant women, and children younger than 5 years.

Currently, Rochester Clinical Research is conducting a study to evaluate an investigational influenza vaccine that is using mRNA technology in adults who are 50 years or older. Vaccines lower your chances of getting a disease by working with your body’s natural defense: your immune system. When you get a vaccine, your body’s immune system responds and builds protection. Typically, vaccines for viruses are made from a weakened or inactive version of the virus. However, this investigational mRNA vaccine is different and contains mRNA that is entirely made in a laboratory and instructs your body to make small pieces of proteins. An mRNA vaccine has the potential to offer broader protection by responding to changes in seasonal influenza strains more quickly, creating stronger immune responses and improving safety in older adults.

This study will last approximately 12 months with 1 visit to our office. Study-related tests and procedures are available to participants at no cost and health insurance are not required nor needed. Compensation of up to $$$ is available for time and travel to those who qualify.

Qualifications

  • 50 years or older
  • Able to comply with study and sign an informed consent
  • *Please note, that other conditions may apply